Cargando…

Elimination In Vivo of Developing T Cells by Natural Killer Cells

Natural killer cells gauge the absence of self class I MHC on susceptible target cells by means of inhibitory receptors such as members of the Ly49 family. To initiate killing by natural killer cells, a lack of inhibitory signals must be accompanied by the presence of activating ligands on the targe...

Descripción completa

Detalles Bibliográficos
Autores principales: Schott, Eckart, Bonasio, Roberto, Ploegh, Hidde L.
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2003
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2194238/
https://www.ncbi.nlm.nih.gov/pubmed/14568980
http://dx.doi.org/10.1084/jem.20030918
_version_ 1782147658210607104
author Schott, Eckart
Bonasio, Roberto
Ploegh, Hidde L.
author_facet Schott, Eckart
Bonasio, Roberto
Ploegh, Hidde L.
author_sort Schott, Eckart
collection PubMed
description Natural killer cells gauge the absence of self class I MHC on susceptible target cells by means of inhibitory receptors such as members of the Ly49 family. To initiate killing by natural killer cells, a lack of inhibitory signals must be accompanied by the presence of activating ligands on the target cell. Although natural killer cell–mediated rejection of class I MHC–deficient bone marrow (BM) grafts is a matter of record, little is known about the targeting in vivo of specific cellular subsets by natural killer cells. We show here that development of class I MHC–negative thymocytes is delayed as a result of natural killer cell toxicity after grafting of a class I MHC–positive host with class I MHC–negative BM. Double positive thymocytes that persist in the presence of natural killer cells display an unusual T cell receptor–deficient phenotype, yet nevertheless give rise to single positive thymocytes and yield mature class I MHC–deficient lymphocytes that accumulate in the class I MHC–positive host. The resulting class I MHC–deficient CD8 T cells are functional and upon activation remain susceptible to natural killer cell toxicity in vivo. Reconstitution of class I MHC–deficient BM precursors with H2-K(b) by retroviral transduction fully restores normal thymic development.
format Text
id pubmed-2194238
institution National Center for Biotechnology Information
language English
publishDate 2003
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21942382008-04-11 Elimination In Vivo of Developing T Cells by Natural Killer Cells Schott, Eckart Bonasio, Roberto Ploegh, Hidde L. J Exp Med Article Natural killer cells gauge the absence of self class I MHC on susceptible target cells by means of inhibitory receptors such as members of the Ly49 family. To initiate killing by natural killer cells, a lack of inhibitory signals must be accompanied by the presence of activating ligands on the target cell. Although natural killer cell–mediated rejection of class I MHC–deficient bone marrow (BM) grafts is a matter of record, little is known about the targeting in vivo of specific cellular subsets by natural killer cells. We show here that development of class I MHC–negative thymocytes is delayed as a result of natural killer cell toxicity after grafting of a class I MHC–positive host with class I MHC–negative BM. Double positive thymocytes that persist in the presence of natural killer cells display an unusual T cell receptor–deficient phenotype, yet nevertheless give rise to single positive thymocytes and yield mature class I MHC–deficient lymphocytes that accumulate in the class I MHC–positive host. The resulting class I MHC–deficient CD8 T cells are functional and upon activation remain susceptible to natural killer cell toxicity in vivo. Reconstitution of class I MHC–deficient BM precursors with H2-K(b) by retroviral transduction fully restores normal thymic development. The Rockefeller University Press 2003-10-20 /pmc/articles/PMC2194238/ /pubmed/14568980 http://dx.doi.org/10.1084/jem.20030918 Text en Copyright © 2003, The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Article
Schott, Eckart
Bonasio, Roberto
Ploegh, Hidde L.
Elimination In Vivo of Developing T Cells by Natural Killer Cells
title Elimination In Vivo of Developing T Cells by Natural Killer Cells
title_full Elimination In Vivo of Developing T Cells by Natural Killer Cells
title_fullStr Elimination In Vivo of Developing T Cells by Natural Killer Cells
title_full_unstemmed Elimination In Vivo of Developing T Cells by Natural Killer Cells
title_short Elimination In Vivo of Developing T Cells by Natural Killer Cells
title_sort elimination in vivo of developing t cells by natural killer cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2194238/
https://www.ncbi.nlm.nih.gov/pubmed/14568980
http://dx.doi.org/10.1084/jem.20030918
work_keys_str_mv AT schotteckart eliminationinvivoofdevelopingtcellsbynaturalkillercells
AT bonasioroberto eliminationinvivoofdevelopingtcellsbynaturalkillercells
AT ploeghhiddel eliminationinvivoofdevelopingtcellsbynaturalkillercells